This protocol is judged by an institutional evaluate board, an unbiased team that opinions any scientific trials involving humans. If a study involves a Schedule I drug, when the board approves the protocol as ethical, the researchers really need to submit an application for an investigational new drug (IND) range through the FDA.Weiser urged socia